Quince Therapeutics, Inc.
QNCX
Price:
$1.71
Market Cap:
$77.75M
Quince Therapeutics, Inc., a biopharmaceutical company, focuses on advancing precision therapeutics for debilitating and rare diseases. The company has discovered a broad bone-targeting drug platform to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease. Its lead compound is NOV004, an anabolic peptide engineered to precisely target and concentrate at the bone fracture site The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. Quince Therapeutics, Inc. was incorporated in 2012 and is headquartered in South San Francisco, California.
Industry
Biotechnology
IPO Date
2019-05-09
Stock Exchange
NASDAQ
Ticker
QNCX
PE Ratio
[-1.23]
ROE
[-172.68%]
Current Ratio
[4.05]
Dividend Yield
[0%]
Enterprise Value
[85.63M]
Dividend History
The ROE as of July 2025 (TTM) for Quince Therapeutics, Inc. (QNCX) is -172.68%
According to Quince Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -172.68%. This represents a change of 257.01% compared to the average of -48.37% of the last 4 quarters.
Quince Therapeutics, Inc. (QNCX) Historical ROE (quarterly & annually)
How has QNCX ROE performed in the past?
The mean historical ROE of Quince Therapeutics, Inc. over the last ten years is -48.21%. The current -172.68% ROE has changed 258.18% with respect to the historical average. Over the past ten years (40 quarters), QNCX's ROE was at its highest in in the March 2018 quarter at 108.87%. The ROE was at its lowest in in the March 2025 quarter at -80.89%.
Average
-48.21%
Median
-40.75%
Minimum
-188.51%
Maximum
60.33%
Quince Therapeutics, Inc. (QNCX) ROE by Quarter and Year
Discovering the peaks and valleys of Quince Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 411.04%
Maximum Annual ROE = 60.33%
Minimum Annual Increase = -128.95%
Minimum Annual ROE = -188.51%
| Year | ROE | Change |
|---|---|---|
| 2024 | -188.51% | 411.04% |
| 2023 | -36.89% | -28.17% |
| 2022 | -51.36% | -31.82% |
| 2021 | -75.33% | 68.85% |
| 2020 | -44.61% | 40.02% |
| 2019 | -31.86% | 82.39% |
| 2018 | -17.47% | -128.95% |
Quince Therapeutics, Inc. (QNCX) Average ROE
How has QNCX ROE performed in the past?
The current ROE of Quince Therapeutics, Inc. (QNCX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-92.25%
5-year avg
-79.34%
10-year avg
-48.21%
Quince Therapeutics, Inc. (QNCX) ROE vs. Peers
How is QNCX’s ROE compared to its peers?
Quince Therapeutics, Inc.’s ROE is greater than Heart Test Laboratories, Inc. (-174.83%), greater than LENZ Therapeutics, Inc. (-23.74%), greater than PMV Pharmaceuticals, Inc. (-32.54%), greater than RAPT Therapeutics, Inc. (-81.47%), greater than Unicycive Therapeutics, Inc. (-78.04%),
| Company | ROE | Market cap |
|---|---|---|
| -174.83% | $4.69M | |
| -23.74% | $945.99M | |
| -32.54% | $63.90M | |
| -81.47% | $138.99M | |
| -78.04% | $68.95M |
Build a custom stock screener for Quince Therapeutics, Inc. (QNCX) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Quince Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Quince Therapeutics, Inc. (QNCX) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Quince Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Quince Therapeutics, Inc.'s ROE?
How is the ROE calculated for Quince Therapeutics, Inc. (QNCX)?
What is the highest ROE for Quince Therapeutics, Inc. (QNCX)?
What is the 3-year average ROE for Quince Therapeutics, Inc. (QNCX)?
What is the 5-year average ROE for Quince Therapeutics, Inc. (QNCX)?
How does the current ROE for Quince Therapeutics, Inc. (QNCX) compare to its historical average?